These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 38713941)

  • 1. Advanced nanoparticle strategies for optimizing RNA therapeutic delivery in neurodegenerative disorders.
    Naimi N; Seyedmirzaei H; Hassannejad Z; Soltani Khaboushan A
    Biomed Pharmacother; 2024 Jun; 175():116691. PubMed ID: 38713941
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current insights on lipid nanocarrier-assisted drug delivery in the treatment of neurodegenerative diseases.
    Teixeira MI; Lopes CM; Amaral MH; Costa PC
    Eur J Pharm Biopharm; 2020 Apr; 149():192-217. PubMed ID: 31982574
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treating Alzheimer's disease using nanoparticle-mediated drug delivery strategies/systems.
    Roghani AK; Garcia RI; Roghani A; Reddy A; Khemka S; Reddy RP; Pattoor V; Jacob M; Reddy PH; Sehar U
    Ageing Res Rev; 2024 Jun; 97():102291. PubMed ID: 38614367
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nanoparticles for Targeted Brain Drug Delivery: What Do We Know?
    Pinheiro RGR; Coutinho AJ; Pinheiro M; Neves AR
    Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34769082
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell-Penetrating Peptides: Promising Therapeutics and Drug-Delivery Systems for Neurodegenerative Diseases.
    Pirhaghi M; Mamashli F; Moosavi-Movahedi F; Arghavani P; Amiri A; Davaeil B; Mohammad-Zaheri M; Mousavi-Jarrahi Z; Sharma D; Langel Ü; Otzen DE; Saboury AA
    Mol Pharm; 2024 May; 21(5):2097-2117. PubMed ID: 38440998
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advances in the treatment of neurodegenerative disorders employing nanoparticles.
    Spuch C; Saida O; Navarro C
    Recent Pat Drug Deliv Formul; 2012 Apr; 6(1):2-18. PubMed ID: 22272933
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Research Progress of Nanocarriers for the Treatment of Alzheimer's Disease.
    Li L; Zhang J; Huang X; Du J; Tu Z; Wu H; Liu X; Yuan M
    Curr Pharm Des; 2023; 29(2):95-115. PubMed ID: 36529920
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nanoparticle-mediated brain drug delivery: Overcoming blood-brain barrier to treat neurodegenerative diseases.
    Saraiva C; Praça C; Ferreira R; Santos T; Ferreira L; Bernardino L
    J Control Release; 2016 Aug; 235():34-47. PubMed ID: 27208862
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug delivery for neurodegenerative diseases is a problem, but lipid nanocarriers could provide the answer.
    Rafe MR
    Nanotheranostics; 2024; 8(1):90-99. PubMed ID: 38164504
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Therapeutic Benefits of Intravenously Administrated Nanoparticles in Stroke and Age-related Neurodegenerative Diseases.
    Farhoudi M; Sadigh-Eteghad S; Mahmoudi J; Farjami A; Mahmoudian M; Salatin S
    Curr Pharm Des; 2022; 28(24):1985-2000. PubMed ID: 35676838
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nanotechnology-based Targeting of Neurodegenerative Disorders: A Promising Tool for Efficient Delivery of Neuromedicines.
    Rajpoot K
    Curr Drug Targets; 2020; 21(8):819-836. PubMed ID: 31906836
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intranasal nanoparticulate delivery systems for neurodegenerative disorders: a review.
    Babu SR; Shekara HH; Sahoo AK; Harsha Vardhan PV; Thiruppathi N; Venkatesh MP
    Ther Deliv; 2023 Sep; 14(9):571-594. PubMed ID: 37691577
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nanotechnology-based drug delivery systems for targeting, imaging and diagnosis of neurodegenerative diseases.
    Pehlivan SB
    Pharm Res; 2013 Oct; 30(10):2499-511. PubMed ID: 23959851
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Challenges and opportunities in CNS delivery of therapeutics for neurodegenerative diseases.
    Barchet TM; Amiji MM
    Expert Opin Drug Deliv; 2009 Mar; 6(3):211-25. PubMed ID: 19290842
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting nanoparticles across the blood-brain barrier with monoclonal antibodies.
    Loureiro JA; Gomes B; Coelho MA; do Carmo Pereira M; Rocha S
    Nanomedicine (Lond); 2014 Apr; 9(5):709-22. PubMed ID: 24827845
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potential Gene Therapy Towards Treating Neurodegenerative Disea ses Employing Polymeric Nanosystems.
    Bangde P; Atale S; Dey A; Pandit A; Dandekar P; Jain R
    Curr Gene Ther; 2017; 17(2):170-183. PubMed ID: 28494742
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Solid lipid nanoparticles as a drug delivery system for the treatment of neurodegenerative diseases.
    Cacciatore I; Ciulla M; Fornasari E; Marinelli L; Di Stefano A
    Expert Opin Drug Deliv; 2016 Aug; 13(8):1121-31. PubMed ID: 27073977
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Review of the Common Neurodegenerative Disorders: Current Therapeutic Approaches and the Potential Role of Nanotherapeutics.
    Lamptey RNL; Chaulagain B; Trivedi R; Gothwal A; Layek B; Singh J
    Int J Mol Sci; 2022 Feb; 23(3):. PubMed ID: 35163773
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multifunctional Nanocarriers for Alzheimer's Disease: Befriending the Barriers.
    Ansari MA; Tripathi T; Venkidasamy B; Monziani A; Rajakumar G; Alomary MN; Alyahya SA; Onimus O; D'souza N; Barkat MA; Al-Suhaimi EA; Samynathan R; Thiruvengadam M
    Mol Neurobiol; 2024 May; 61(5):3042-3089. PubMed ID: 37966683
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nanoparticles-based delivery system and its potentials in treating central nervous system disorders.
    Liu T; Xie Q; Dong Z; Peng Q
    Nanotechnology; 2022 Aug; 33(45):. PubMed ID: 35917704
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.